CRISPR-based repair of RBM20 disease variants to treat and prevent dilated cardiomyopathy
| Institution | Europäisches Laboratorium für Molekularbiologie (EMBL) |
|---|---|
| Project leader | Lars Steinmetz |
| Site | Heidelberg/Mannheim |
| Project type | Standortprojekt |
| Funding | € 206.203,53 |
| Begin | 01.01.2021 |
| End | 31.12.2022 |
Förderkennzeichen
81Z0500401
Projektnummer
1316